ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL Angle Plc

21.25
3.50 (19.72%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.50 19.72% 21.25 20.50 22.00 23.50 18.50 18.50 10,311,990 16:17:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -2.55 55.37M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 17.75p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £55.37 million. Angle has a price to earnings ratio (PE ratio) of -2.55.

Angle Share Discussion Threads

Showing 33176 to 33194 of 33200 messages
Chat Pages: 1328  1327  1326  1325  1324  1323  1322  1321  1320  1319  1318  1317  Older
DateSubjectAuthorDiscuss
07/5/2024
21:22
Higher vols would suggest some continued momentum, tomorrow is another day…
gspanner
07/5/2024
21:21
The chart really does say 50p on this one before long - very soon, if more good news to come
spa362
07/5/2024
21:17
Upwards movement looks set to continue this week. Excellent chart. Make your own choices...
spa362
07/5/2024
20:27
kryptonsnake

I'm not suggesting you don't mean well or that your heart's not in the right place, but it's surely unnecessary to sneer at other correspondents ("LOL" - what's so funny?) or to hiss at them ("sss") or somehow pretend that you're a snake. In case you weren't aware, most people don't like snakes. It's hard to take you seriously if you post immaturely.

pldazzle
07/5/2024
19:16
Roche, thermo Fisher, illumia, Bayer, bioview, Abbott, Artios, ones that have links with AGL. To some degree already either directly or indirectly. A few more I'm. Sure others will. Add to that of possibllities

Millwall I asked about them recently the reply see the results for update basically. I get the feeling we are due at least one more rns before results possibly more

bones698
07/5/2024
19:09
Kryptonsnake. Nobody is right and nobody is wrong yet. It depends on whether more good news is coming. If nothing by mid next week then it will drift down again.
purchaseatthetop
07/5/2024
19:08
Even more reason to fast track FDA for prostrate !!!!
millwallfan
07/5/2024
19:07
Thanks ST. Definite opportunities.

New game anyone?
Who can name the additional 11 farmers?

boris cobaka
07/5/2024
18:32
Almost 100,000 cancer patients have now benefitted from early access to the latest and most innovative treatments, thanks to the NHS Cancer Drugs Fund.-The current CDF budget of £340 million is 70% more than the previous CDF and is used alongside NHS England's Innovative Medicines Fund of £340 million, meaning that the health service has a TOTAL of £680M ringfenced funding for FAST TRACKING NEW medicines.Https://www.england.nhs.uk/2024/03/100000-patients-receive-early-access-to-latest-cancer-therapies-on-nhs/-Some of the latest treatments which have been funded through the NHS Cancer Drugs Fund include:• Olaparib for breast cancer and prostate cancer – two of the most common cancers – in April 2023• A new immunotherapy – Dostarlimab – for advanced womb cancer in March 2024• A potentially curative treatment – Glofitamab – for an aggressive type of blood cancer, diffuse large B-cell lymphoma, in October 2023• CAR-T cancer therapies for two forms of blood cancer – Tecartus and Yescarta – in April 2023• Pembrolizumab, an immunotherapy for advanced cervical cancer, was made available in March 2023, becoming the first new life-extending treatment for incurable cervical cancer in almost fifteen years.-• INTERESTINGLY:NHS strikes landmark deal for drug to treat TWO MOST COMMON cancers:• Hundreds of patients with BREAST cancer and advanced PROSTATE cancer could benefit from a breakthrough targeted therapy, after the NHS agreed a landmark commercial deal to roll-out the drug to treat forms of the two most common cancers in England.• The drug, olaparib (Lynparza®), targets cancers with mutations in the BRCA genes, and works by stopping cancer cells from being able to repair their DNA by blocking a molecule called PARP, which causes the cancerous cells to die.• Around 550 men with advanced prostate cancer, and 300 women with HER2-negative early breast cancer who are at high risk of the disease returning, will be eligible for this new drug each year in England.• NHS England has negotiated a commercial deal with the manufacturer, UK-based ASTRAZENECA, enabling the National Institute for Health and Care Excellence (NICE) to make a positive recommendation of the drug for treatment of BRCA-mutated BREAST and PROSTATE cancers.Https://www.england.nhs.uk/2023/04/nhs-strikes-landmark-deal-for-drug-to-treat-two-most-common-cancers/-For info (unsure if it was referenced before? If so ignore).
5oletrader
07/5/2024
17:00
Maybe he's doing some online shopping?
boris cobaka
07/5/2024
16:57
Friday is the most regular day for news with AGL over the years. Not expecting news every week but the news that does come could be very good indeed.
I'm talks with 11 other ocmpnaoes, 6 of them household names. Enough said

bones698
07/5/2024
16:37
Well a pretty good day on no additional rns so the weekend press and the post rns interviews worked their magic...
Buying tailed off toward the cob so I wouldn't be surprised to see a massive shake attempt first thing tomorrow am. Maybe even as low as 16p to trigger a few stops set on buys 20p+

boris cobaka
07/5/2024
16:26
PATT

Are you going to admit you were wrong on 2 counts today

Nobody got spiked and the share price rise has been sustained over the last few sessions

Judging by the 6 downvotes on your post nobody here agrees with you


LOLsss


purchaseatthetop7 May '24 - 08:46 - 24471 of 24552
0 1 6
People are going to have got spiked here today. Until funding is resolved no rise is sustainable.

kryptonsnake
07/5/2024
16:04
I think a few thought that the follow up interviews after the last rns woukdnlt reveal anything new or price sensitive. Unless I missed it in the rns the comment about being in discussion with 11 large pharma was new information although very non specific.
I think alot of today's rise was on the back of that as much as the original rns.

boris cobaka
07/5/2024
16:03
As I told you in late April when you also took umbrage for me posting after selling I remain interested. It’s a cracking share given the volatility, I find it fascinating. I do agree what I post doesn’t impact the price.

Thanks for your concern but I’d be more worried about my own position than how often someone posts. Especially if I was miles underwater mate.

As a general observation I’d probably post less if I didn’t have a succession of worried bulls questioning my motives and telling me what I’m allowed to talk about

adw198
07/5/2024
16:02
zeus, why do you not edit your posts rather than put another post correcting a previous post ?
dexdringle
07/5/2024
16:01
Hey Zeus

Ignore Adw198. He's suffering from sellers remorse


LOLsss

kryptonsnake
07/5/2024
15:59
iPhone. Cant edit via the app
zeus19
07/5/2024
15:57
zeus, why do you edit your posts rather than put another post correcting a previous post ?
dexdringle
Chat Pages: 1328  1327  1326  1325  1324  1323  1322  1321  1320  1319  1318  1317  Older

Your Recent History

Delayed Upgrade Clock